Human dermal microvascular arterial and venous blood endothelial cells and their use in bioengineered dermo-epidermal skin substitutes in vitro and in vivo
Creators
- 1. Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, Zurich, Switzerland
- 2. Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
Description
The bio-engineering of vascular networks is pivotal to create complex tissues and
organs in vitro for regenerative medicine applications. The vascular plexus is needed for a
sufficient and fast blood supply after transplantation, and, thus, required for the survival and
function of the engineered tissue or organ. Hence, human endothelial cells are an attractive
source for bio-engineering purposes, for example human dermal microvascular endothelial
cells (HDMECs).
So far, a discrimination between arterial and venous blood endothelial cells after
isolation of HDMECs from skin biopsies and if arterial and/or venous capillaries are formed in
pre-vascularized bio-engineered substitutes was not investigated.
In this study, we investigated employedby single cell sequencing for to
investigate/compare human arterial and venous endothelial cell markers in human fetal and
juvenile skin. Further, we analyzed if these markers are present after isolation of human skin
derived endothelial cells under 2D culture conditions. In additionFinally, we investigated
assessed if human endothelial cells form distinct arterial and venous capillaries in 3D
collagen type I hydrogels, and if these capillaries retain their identity after transplantation.
We determinedOur results showed that arterial and venous endothelial cell markers
such as NRP1 and NR2F2 are expressed both in fetal and juvenile skin, and are retained after
isolation in culture. We could show demonstrate that arterial and venous endothelial cells
maintain their differentiation status and form arterial and venous capillaries in 3D in vitro
culture systems and that the capillaries inosculate after transplantation.
In summary, we could show that we could bio-engineer human arterial, venous, and
lymphatic capillaries in a human skin substitute in view of regenerative medicine approaches
for clinical applications.
Files
Files
(105.5 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:7c7de0e3f9844ebb1b16f4c17c4956d6
|
105.5 MB | Download |